Related Experiment Video
Updated: Apr 29, 2026

07:16
Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection
Published on: February 9, 2024
1.8K
Single-atom nanozymes: Bridging atomic design and biomedical function through structure-activity-property
Sin Yuan Chong1, Kang Liang2, Jieying Liang1
1School of Chemical Engineering, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, NSW 2052, Australia.
Advanced Drug Delivery Reviews
|April 27, 2026
Summary
Single-atom nanozymes (SAzymes) offer precise metalloenzyme mimicry for biomedical use. This review establishes a framework linking their atomic structure to catalytic function and applications, guiding future nanomedicine development.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Catalysis
Background:
- Single-atom nanozymes (SAzymes) mimic metalloenzymes with high precision.
- Biomedical applications are hindered by limited structure-function understanding and clinical translation challenges.
Purpose of the Study:
- Establish a structure-activity-property relationship (SAPR) framework for SAzymes.
- Bridge atomic-level design with catalytic behavior and biomedical function.
Main Methods:
- Outline principles for constructing single-atom active sites.
- Detail SAzyme design strategies: coordination, electronic structure, defects, and multi-atom sites.
- Analyze how atomic features govern ROS generation, kinetics, and selectivity.
Main Results:
- Atomic-level SAzyme features dictate catalytic processes and biomedical applications.
- SAzymes enhance biosensing sensitivity and reproducibility.
- SAzymes address tumor hypoxia, redox imbalance, and inflammation via ROS catalysis and metabolic modulation.
Conclusions:
- The SAPR framework enables rational design of SAzymes for biosensing and therapy.
- Key challenges include stability, protein corona, scalability, and biosafety.
- This review provides a unified perspective for next-generation SAzyme nanomedicines.
Related Concept Videos
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Ribozymes
10.0K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
10.0K
Enzymes
68.8K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
68.8K

